Delivery Order SPE2DB25D2204-SPE2DB25FTGNS
Award Date
5/28/25
Potential Completion Date
5/29/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 syringes. The order is a firm fixed-price contract with a ceiling value of $7,549.74 and a performance period ending on May 14, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of GARDASIL 9 syringes. The $20,463.48 firm-fixed-price contract has an ultimate completion date of August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these medical supplies through an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. This IDC enables the DLA to...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, and has a ceiling value of $26,152.42. The contract is a Firm Fixed Price type and runs through March 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,485.56 fixed-price delivery order is for the supply of GARDASIL 9 vaccine syringes, a medical product used for immunization. The order has a period of performance through May 12, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 syringes. The contract is a firm fixed-price delivery order with a ceiling value of $12,410.78 and a completion date of September 27, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 SYRINGE 0.5ML. The contract has a firm fixed-price, is not set-aside, and has a ceiling value of $6,989.84. The period of performance extends through May 21, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, that allows the...
This is a $12,172.82 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 vaccine syringes. The contract has a firm fixed price and an ultimate completion date of February 27, 2025. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of GARDASIL 9 syringes, a critical pharmaceutical product, with a ceiling value of $47,651.93 and a performance period through August 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,252.15, is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 syringes, a vaccine product, with a ceiling value of $2,426.07 and a period of performance through May 19, 2025. The contract is designated as a Firm Fixed Price Delivery Order, without any set-aside requirements. AmerisourceBergen Drug Corp holds a significant...